Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...
Asıl Yazarlar: | Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer Nature
2020
|
Benzer Materyaller
-
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Yazar:: Yasunori Watanabe, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01) -
Structure of the Lassa virus glycan shield provides a model for immunological resistance
Yazar:: Watanabe, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Antibodies expose multiple weaknesses in the glycan shield of HIV.
Yazar:: Crispin, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Antibodies expose multiple weaknesses in the glycan shield of HIV.
Yazar:: Crispin, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
The impact of sequence diversity on the glycan shield of HIV-1 immunogens
Yazar:: Seabright, GE
Baskı/Yayın Bilgisi: (2019)